Mutant xylan biosynthetic enzymes capable of dominant suppression of xylan biosynthesis

US11208666B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• Andrew Brandon · Williamsport, US
• Henrik Vibe Scheller · Millbrae, US
• Dominique Loque · Geneva, CH

Key dates

• Filing date: Dec 19, 2017
• Grant date: Dec 28, 2021
• Expiry date: Dec 5, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N15/8246
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention provides for a polypeptide capable of dominant suppression of a first naturally occurring IRX10, wherein the polypeptide comprises an amino acid sequence having at least 70% identity as compared to a second naturally occurring IRX10 wherein the polypeptide comprises one or more of the conserved amino acid indicated in FIG. 2 substituted with a different amino acid residue.